Revvity aims to expand the FDA-cleared menu for the EUROIMMUN family of ChLIA automation solutions to serve a wider patient pool.

"Revvity wins FDA clearance for ChLIA assay in free testosterone measurement" was originally created and published by Medical ...

Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA ...

This innovative test is the first of its kind to receive FDA clearance for direct quantitative measurement of free testosterone levels, marking a significant advancement in diagnostic capabilities ...

Revvity (RVTY) received 510(k) clearance from FDA for EUROIMMUN's automated chemiluminescence-based immunoassay test for free ...

By staying abreast of signs and risk factors, such as persistent indigestion, unexplained weight loss, or discomfort in the ...

In one particular test, there was a marked difference in ... when oestrogen levels fall and levels of the male hormone testosterone rise - the scores of all but one of the volunteers shot up.

The pursuit of physical perfection has become an obsession for many, particularly in the world of bodybuilding, but the pressure to achieve a chiselled physique has led to a worrying trend: the ...

The discrepancy in HPV screening rates emphasizes a need for gender affirming options for sample collections. Considering the susceptibility and infection rate of transmasculine individuals and ...

--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY), today announced that it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for EUROIMMUN’s automated chemiluminescence-based ...

Sana Biotechnology said a type 1 diabetes (T1D) patient received an allogeneic primary islet cell transplantation without ...